Has India’s Drug Pricing Authority Been Rendered Toothless?
Executive Summary
India has put in place a new panel to act as a 'recommending body' to the National Pharmaceutical Pricing Authority, raising questions about the pricing body’s autonomy and whether its role has been 'usurped'. The pharma industry claims a balanced pricing regime may emerge under the new system but doesn’t rule out inter-department conflicts in the government.